OurCrowd portfolio company The Trendlines Group was featured in Crowdfund Insider, a leading news and information web site covering the emerging global industry of disruptive finance. The Trendlines Group establishes, invests in, and develops innovation-based medical and agritech businesses that improve the human condition.
Trendlines, an Israeli-based tech company that targets the medical and agricultural industry, recently completed its IPO on the Catalist of the SingaporeExhcange trading under the on ticker symbol SGX:42T.
Trendlines Co-Chair and CEO D. Todd Dollinger said, “It was encouraging to see the interest from investors. While Trendlines’ business model is unusual compared to most of the listed companies in Singapore, investors understood Trendlines’ ability to incubate technology-based companies in the medical and agricultural fields, bring them to commercialization, and achieve significant returns for investors. The value of investing in Trendlines is well validated by cornerstone investor B. Braun’s strategic investment in us.”
The Trendlines Group raised $900,000 from OurCrowd investors in May 2013.
Read more on the Crowdfund Insider here.